A real anti-aging preventative medicine for humans might be on the horizon

An anti-aging study is underway to prolong the lives of middle-aged dogs. The study is funded by Novartis Pharmaceuticals which helps to derive some financial gain by developing products for anti-aging applications. 

A 2014 research study backed by the NIH has demonstrated that 20-month old adult mice could have their lives extended by 10 to 14% if given a daily dose of the drug compound derived from a bacteria found on Easter Island. 

This drug compound is called rapamycin and is currently offered by a number pharmaceutical companies that use this compound for various treatments such as for certain lung and cancers, preventing organ transplant rejection by immune system suppression, it coating on stents that prevents scarring and blockage in arteries, and anti-fungal cream. The current market for rapamycin, it’s derivatives and other antiaging compounds is approximately $1 billion worldwide.  

The above information came from a recent February article of Bloomberg BusinessWeek written by Bill Gifford, author of the new book, Spring Chicken.  Gifford’s book is about the science of aging. The article is a pretty good read so it should be a good step in learning more about what’s going on in preventative medicine to treat human aging.

%d bloggers like this: